secwatch.observer — SEC 8-K summary
======================================

Issuer:     EKSO BIONICS HOLDINGS, INC. (CHRN)
CIK:        0001549084
Form:       8-K
Filed at:   2026-09-16T21:05:23+00:00
Accession:  0001493152-26-042947
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ChronoScale extends $2M loan maturity to Nov 12, 2026; permits Ekso Bionics sale
--------------------------------------------------------------------------------

- Term loan of $2.0M outstanding extended to Nov 12, 2026 from Sept 12, 2026 via amendment with B. Riley Commercial Capital.
- Amendment allows sale of Guarantor Ekso Bionics, Inc. as Permitted Disposition, auto-releasing Lender's liens on sold assets/capital stock.
- Waiver dated Apr 23, 2026: Proposed Financing does not accelerate maturity but qualifies as Qualified Financing for conversion right.
- Loan Parties confirm $2M principal outstanding and no defenses; all other Note terms unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1549084/000149315226042947/0001493152-26-042947-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1549084/000149315226042947/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-042947

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer